Jefferson A. de Barros, Departamento de Ciências da Saúde, Faculdade de Medicina do ABC, Santo André, São Paulo. Brasil
Vinicius Gomes-Lippi, Departamento de Dermatologia, Faculdade de Medicina do ABC, São Paulo. Brasil
Débora Terra-Cardia, Departamento de Médicina, Faculdade de Medicina do ABC, Santo André, São Paulo. Brasil
Vitória T. Guimarães-Mizutani, Departamento de Médicina, Faculdade de Medicina do ABC, Santo André, São Paulo. Brasil
Carlos D’Apparecida-Santos-Machado-Filho, Departamento da Disciplina de Dermatologia da Faculdade de Medicina do ABC, Santo André. São Paulo. Brasil
Vitiligo is an acquired pigment disorder of unknown origin, prevalence estimated at 1%. It is characterized by the physical and functional reduction of melanocytes and consequent depigmentation of the skin. The most accepted theories to explain its pathophysiology are genetic predisposition, autoimmune mechanisms and oxidative stress. We report a case of vitiligo in a female patient, who presented a good therapeutic response to the combination of the extract of Brosimum gaudichaudii trécul and khellin, associated with heliotherapy, without adverse effects and good clinical tolerance.
Keywords: Vitiligo. Pharmacological treatment. Brosimum gaudichaudii. Therapeutic use. Quelina.
